Shares of Edwards Lifesciences Corp. EW slid 2.05% to $70.33 Friday, on what proved to be an all-around favorable trading ...

Shares of Edwards Lifesciences Corp. EW slipped 1.44% to $71.80 Thursday, on what proved to be an all-around dismal trading ...

Full Year 2024 Results Key Financial Results Revenue: US$5.44b (up 8.6% from FY ...

Zacks Research boosted their Q1 2025 earnings estimates for shares of Edwards Lifesciences in a research report issued to ...

Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the TD Cowen 45th Annual Health Care ...

Edwards Lifesciences Corporation (NYSE:EW), a leading medical technology company specializing in heart valve therapies and critical care technologies with a market capitalization of $44.9 billion ...

Becton, Dickinson and Co. (BD) has appointed longtime Edwards Lifesciences sales and marketing exec Tim Patz as the new ...

Zovighian said the transition to CEO has been relatively smooth since he joined Edwards in 2015 and spent eight years in ...

Sigma Planning Corp reduced its stake in Edwards Lifesciences Co. (NYSE:EW – Free Report) by 6.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange ...

Embodied carbon reduction strategies helped guide the design of Edwards Lifesciences’ Mussallem Innovation Center, a mix of ...

Looking into the current session, Edwards Lifesciences Inc. EW shares are trading at $71.65, after a 0.28% spike. Moreover, over the past month, the stock spiked by 0.45%, but in the past year, fell ...

Over the last two decades, Edwards Lifesciences has demonstrated that it knows how to maintain leadership through innovation of tissue heart valves. Edwards remains the dominant force in surgical ...